Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- TRADING UPDATES: Shield closer to Canada approval; Angle plans raise
14 Jul 2022 - Angle wins additional contract with large-scale pharma company
22 Jun 2022 - Angle wins cancer monitoring contract for Parasortix system
22 Jun 2022 - TRADING UPDATES: Valereum opens NFT market; Conygar considers raising
16 Jun 2022 - IN BRIEF: Angle's Parsortix performs well on prostate cancer patients
14 Jun 2022 - IN BRIEF: Angle partners with US urology group for Parasortix study
30 May 2022 - TRADING UPDATES: Savannah Energy to develop new projects in Chad
27 May 2022 - IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval
25 May 2022
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
TRADING UPDATES: Shield closer to Canada approval; Angle plans raise
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Angle wins additional contract with large-scale pharma company
(Sharecast News) - Liquid biopsy company Angle has secured an additional contract with its first large-scale pharmaceutical services customer.
Angle wins cancer monitoring contract for Parasortix system
(Alliance News) - Angle PLC on Wednesday said it has secured further business with its "first large scale pharma services" customer.
TRADING UPDATES: Valereum opens NFT market; Conygar considers raising
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
IN BRIEF: Angle's Parsortix performs well on prostate cancer patients
Angle PLC - Surrey, England-based medical diagnostics company - Notes researchers at King's College London published data investigating the role of in...
IN BRIEF: Angle partners with US urology group for Parasortix study
Angle PLC - Surrey, England-based medical diagnostics company - Establishes partnership with MidLantic Urology to evaluate the use of its Parasortix s...
TRADING UPDATES: Savannah Energy to develop new projects in Chad
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval
Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix...
Follow the stocks
